Determination of mephenytoin stereoselective oxidative metabolism in urine by chiral liquid chromatography employing β-cyclodextrin as a mobile phase additive
- 1 January 1992
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 573 (1) , 173-177
- https://doi.org/10.1016/0378-4347(92)80494-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populationsEuropean Journal of Clinical Pharmacology, 1990
- Genetic polymorphism of S-mephenytoin hydroxylationPharmacology & Therapeutics, 1989
- Mephenytoin stereoselective elimination in the rat: II. Comparison of mephenytoin stereoselective clearance during chronic intravenous and hepatic portal vein administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1989
- Metoprolol and mephenytoin oxidation polymorphisms in Far Eastern Oriental subjects: Japanese versus mainland ChineseClinical Pharmacology & Therapeutics, 1989
- Mephenytoin stereoselective elimination in the rat: I. enantiomeric dispostion following intravenous administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1989
- Phenotyping polymorphic drug metabolism in the French Caucasian populationEuropean Journal of Clinical Pharmacology, 1988
- The genetic defect of mephenytoin hydroxylationXenobiotica, 1986
- Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatographyAnalytical Biochemistry, 1985
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983